This inventor holds 1 USPTO granted patent. Top assignee: Precigen, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Amy Wesa: Patent Activity in Chimeric Receptor Therapy.
Introduction
Amy Wesa is an inventor associated with Germantown, Maryland, and Precigen, Inc. Her patent activity includes work related to chimeric receptor therapy.
Latest Patents
The provided information lists one patent for Amy Wesa: “CHIMERIC RECEPTOR THERAPY.” No filing or publication date was provided, so its status as her latest patent cannot be confirmed.
Career Highlights
Wesa is associated with Precigen, Inc., a company working in biotechnology. The supplied information identifies her contribution to an invention in the chimeric receptor therapy field. Her record includes 1 patent.
Collaborations
The provided information names Helen Sabzevari and Cheryl G. Bolinger as Wesa’s coworkers. Their shared association with Precigen, Inc. suggests a professional connection, though specific collaborative roles on the patent were not provided.
Conclusion
Amy Wesa’s listed patent activity centers on chimeric receptor therapy and reflects her association with Precigen, Inc.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile